SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-156284
Filing Date
2021-05-10
Accepted
2021-05-10 16:24:02
Documents
12
Period of Report
2021-05-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d41553d8k.htm   iXBRL 8-K 46421
  Complete submission text file 0001193125-21-156284.txt   166304

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrx-20210505.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20210505_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20210505_pre.xml EX-101.PRE 10969
5 EXTRACTED XBRL INSTANCE DOCUMENT d41553d8k_htm.xml XML 3250
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 21907571
SIC: 2834 Pharmaceutical Preparations